Abstract
Eight cephalosporins were tested for their activity against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci and for their resistance to beta-lactamase from methicillin-resistant, coagulase-negative staphylococci. Susceptibility testing by the agar plate method was evaluated for the effect of inoculum size and duration of incubation. Methicillin-susceptible, coagulase-negative staphylococci were highly susceptible to the cephalosporins, with cephapirin and cepahlothin showing the greatest activity, followed by cefazolin and cefamandole. Methicillin-resistant, coagulase-negative staphylococci displayed nearly total cross-resistance to the cephalosporins. Resistance increased with increasing inoculum size. Beta-Lactamases produced by methicillin-resistant, coagulase-negative staphylococci had a minimal hydrolytic effect on cepahlothin, cephapirin, cefazolin, and cefamandole and no measurable effect on cefoxitin. There was no correlation between the anti-staphylococcal activity and resistance to beta-lactamases.
References
Apr 1, 1979·Canadian Journal of Microbiology·W C OlsonJ N Baldwin
Nov 1, 1978·Southern Medical Journal·W T SiebertT W Williams
Apr 1, 1978·Antimicrobial Agents and Chemotherapy·M LaverdiereL D Sabath
Mar 1, 1978·The Journal of Infectious Diseases·M LaverdiereL D Sabath
Apr 1, 1978·The Journal of Infectious Diseases·W E Farrar, N M O'Dell
Jul 7, 1978·JAMA : the Journal of the American Medical Association·M A Parker, C U Tuazon
Sep 1, 1978·Antimicrobial Agents and Chemotherapy·G L Archer
Nov 1, 1976·Medicine·A S Cross, R T Steigbigel
Dec 1, 1976·Annals of Surgery·L D Edwards
Jun 11, 1976·The Journal of Infectious Diseases·W E Farrar, P K Gramling
Oct 1, 1972·Journal of Pharmaceutical Sciences·J P Hou, J W Poole
Aug 1, 1973·Archives of Internal Medicine·T F Keys, W L Hewitt
Aug 1, 1963·Proceedings of the Society for Experimental Biology and Medicine·J O KJELLANDERM FINLAND
Citations
Oct 1, 1983·European Journal of Clinical Microbiology·A Tselenis-KotsowilisJ Papavassiliou
May 1, 1986·Diagnostic Microbiology and Infectious Disease·J J MordentiG F Brooks
Mar 21, 1981·Lancet·C Marks, B H Cummins
Mar 21, 1981·Lancet·P J Geiseler
May 1, 1984·Antimicrobial Agents and Chemotherapy·R F FrongilloS Pauluzzi
Oct 1, 1986·Antimicrobial Agents and Chemotherapy·R J FassL W Ayers
Jan 1, 1987·Antimicrobial Agents and Chemotherapy·R E MenziesD MacCulloch
Nov 1, 1984·American Journal of Ophthalmology·J A KhanC H Ide
Apr 30, 1998·Infection·Y Matrai-KovalskisR Dagan
Oct 1, 1988·Ophthalmology·J L DavisR K Forster
Jun 1, 1981·The Journal of Hospital Infection·M PapapetropoulosN J Legakis
Mar 1, 1986·The Journal of Hospital Infection·S Ponce de LeonR P Wenzel
Feb 1, 1981·The Annals of Thoracic Surgery·E R GreenC H Nightingale
May 14, 2003·Pharmacotherapy·William DarkoDavid E Lehmann
Oct 1, 1981·Journal of Neurosurgery·M E GombertM Cummings
Sep 1, 2005·The Journal of Bone and Joint Surgery. British Volume·M Al-MaiyahP J Gregg
Oct 1, 1985·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·B G Hansen
Dec 1, 1986·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·V T RosdahlA M Knudsen
Apr 1, 1985·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·B G Hansen, K Rosendal
Mar 30, 2019·Frontiers in Microbiology·Hiroyuki KusadaYoichi Kamagata
Dec 1, 1983·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·B G Hansen
Sep 5, 1988·The Medical Journal of Australia·P McIntyreD Tudehope
Nov 1, 1982·Journal of Clinical Microbiology·C G Gemmell, J E Dawson
Apr 1, 1990·The Journal of Pediatrics·C C Patrick